Beijing Wandong Medical TechnologyLtd Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Jinsong Song
Chief executive officer
CN¥103.8k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.1yrs |
| CEO ownership | n/a |
| Management average tenure | 3yrs |
| Board average tenure | 3.6yrs |
Recent management updates
Recent updates
There's Reason For Concern Over Beijing Wandong Medical Technology Co.,Ltd.'s (SHSE:600055) Massive 28% Price Jump
Nov 12
Returns On Capital At Beijing Wandong Medical TechnologyLtd (SHSE:600055) Paint A Concerning Picture
Oct 23Beijing Wandong Medical Technology Co.,Ltd.'s (SHSE:600055) Price Is Out Of Tune With Earnings
Sep 26Beijing Wandong Medical TechnologyLtd's (SHSE:600055) Returns On Capital Not Reflecting Well On The Business
Jun 25We Think You Should Be Aware Of Some Concerning Factors In Beijing Wandong Medical TechnologyLtd's (SHSE:600055) Earnings
May 03What Beijing Wandong Medical Technology Co.,Ltd.'s (SHSE:600055) 26% Share Price Gain Is Not Telling You
Mar 07CEO
Jinsong Song (57 yo)
1.1yrs
Tenure
CN¥103,800
Compensation
Mr. Jinsong Song serves as President and Director at Beijing Wandong Medical Technology Co.,Ltd. since December 08, 2023. He served as a Senior Vice President at Shanghai Fosun Pharmaceutical (Group) Co.,...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & Director | 1.1yrs | CN¥103.80k | no data | |
| VP & CFO | 9.6yrs | CN¥1.81m | no data | |
| Board Secretary | no data | CN¥1.29m | no data | |
| Vice President | 3.6yrs | no data | no data | |
| Vice President | 2.4yrs | CN¥1.16m | no data | |
| Accounting Supervisor | no data | no data | no data | |
| Chief Administrative Officer | no data | CN¥786.50k | no data |
3.0yrs
Average Tenure
55yo
Average Age
Experienced Management: 600055's management team is considered experienced (3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President & Director | 1.1yrs | CN¥103.80k | no data | |
| Chairman of the Supervisory Board | 3.6yrs | CN¥961.20k | 0.00012% CN¥ 12.2k | |
| Chairman | no data | no data | no data | |
| Independent Director | 3.6yrs | CN¥100.00k | no data | |
| Member of the Supervisory Board | 8.8yrs | no data | no data | |
| Director | 3.6yrs | no data | no data | |
| Director | 3.6yrs | no data | no data | |
| Independent Director | 3.6yrs | CN¥100.00k | no data |
3.6yrs
Average Tenure
59yo
Average Age
Experienced Board: 600055's board of directors are considered experienced (3.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/05 13:17 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Beijing Wandong Medical Technology Co.,Ltd. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jie Ma | Cinda Securities Co., Ltd |
| Guoping Jiang | Everbright Securities Co. Ltd. |
| Weina Jiang | Guosen Securities Co., Ltd. |